Idexx Laboratories Inc /de (IDXX) Files Form 4 Insider Selling : William T End Sells 4,924 Shares

Idexx Laboratories Inc /de (IDXX): William T End , director of Idexx Laboratories Inc /de sold 4,924 shares on May 5, 2016. The Insider selling transaction was reported by the company on May 5, 2016 to the Securities and Exchange Commission. The shares were sold at $85.87 per share for a total value of $422,825.34 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Feb 26, 2016, Michael J Phd Williams (Executive Vice President) sold 2,000 shares at $71.93 per share price.On Feb 25, 2016, M Anne Szostak (director) purchased 2,000 shares at $69.94 per share price.Also, On Feb 11, 2016, Barry C Johnson (director) sold 9,054 shares at $68.90 per share price.On Feb 11, 2016, Thomas Craig (director) sold 2,054 shares at $69.52 per share price.

Shares of IDEXX Laboratories (IDXX) ended Wednesday, May 4, 2016 session in red amid volatile trading. The shares closed down -0.15 points or -0.18% at $85 with 6,02,340 shares getting traded. Post opening the session at $84.72, the shares hit an intraday low of $83.65 and an intraday high of $85.46 and the price vacillated in this range throughout the day. The company has a market cap of $7,610 M and the number of outstanding shares has been calculated to be 8,95,31,171 shares. The 52-week high of IDEXX Laboratories is $85.46 and the 52-week low is $61.58.

IDEXX Laboratories Money Flow Index Chart

Company has been under the radar of several Street Analysts.IDEXX Laboratories is Reiterated by Canaccord Genuity to Buy and the brokerage firm has raised the Price Target to $ 85 from a previous price target of $80 .The Rating was issued on Apr 19, 2016.IDEXX Laboratories is Initiated by CL King to Neutral. The Rating was issued on Apr 1, 2016.IDEXX Laboratories is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 85 from a previous price target of $80 .The Rating was issued on Mar 21, 2016.

IDEXX Laboratories Inc. develops manufactures and distributes products and provides services primarily for the companion animal veterinary livestock and poultry water testing and dairy markets. The Company sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include Companion Animal Group (CAG) Water Livestock Poultry and Dairy and Other. Its Products and services include point-of-care veterinary diagnostic products; veterinary reference laboratory diagnostic and consulting services; practice management systems and services and digital imaging systems; biological materials testing laboratory animal diagnostic instruments and services; diagnostic health-monitoring and food safety testing products for livestock poultry and dairy; products that test water for microbiological contaminants and point-of-care electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Leave a Reply

IDEXX Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on IDEXX Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.